Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 8260644Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Biochemistry
NIH Funding · FY2026
Linked Award Amount
$1.6M
Full award amounts, FY2026
Award Records
3
Records listing this PI
Award-Linked Rank
#4,689
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2026 award records by amount
NIH award records listing Michal Toborek as a PI. Multi-PI records show the full award amount for context.
- 5R01DA059849-03R01Inflammasome Activation and Gut-Brain Axis Dysregulation in HIV and Methamphetamine-Associated Depression$575.4Kaward amount
- 1R01DA066132-01R01Molecular synergy of HIV infection of brain pericytes and methamphetamine use$516.9Kaward amount
- 5R01ES036983-02R01Adolescent exposure to PCBs as a risk factor for the development of depression$499.9Kaward amount
Award organization
Organizations that administered FY2026 awards listing Michal Toborek as a PI.
FY2026 award administered by University of Miami School of Medicine (FL).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardUniversity of Miami School of Medicine
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #3562
- 2024Entered Top 25% NationallyRanked #3562
- 2025R01 Grant Holder
- 2026$5M Cumulative Funding
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Michal Toborek.